Galectin-3 Reflects Mitral Annular Plane Systolic Excursion Being Assessed by Cardiovascular Magnetic Resonance Imaging

Table 4

(a) Multivariable logistic regression model for evaluating the ability of galectin-3 to identify patients with reduced MAPSE of <11 mm. (b) Multivariable logistic regression for evaluating the ability of galectin-3 to identify patients with reduced MAPSE of <8 mm.

	Adjusted odds ratio		Adjusted value
(a)
Galectin-3 (≥16.2 ng/mL)	3.53	1.24–10.05	0.018
NT-proBNP (≥285.2 pg/mL)	4.34	1.48–12.75	0.007
	1.61	0.54–4.77	0.39
Age	0.98	0.95–1.02	0.49
Creatinine	0.84	0.12–5.69	0.86
(b)
Galectin-3 (≥17.5 ng/mL)	3.18	0.93–10.82	0.06
NT-proBNP (≥808.0 pg/mL)	8.50	2.34–30.86	0.001
Age	0.98	0.94–1.03	0.51
	1.28	0.36–4.50	0.70
Creatinine	1.19	0.33–4.25	0.77

Bold values indicate statistically significant values ().
An adjusted odds ratio of >1 indicates an association of male gender with reduced MAPSE.
Confidence interval.